Athena Countouriotis's Net Worth
$19.5 Million
Who is Athena Countouriotis?
Athena Countouriotis has an estimated net worth of $19.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., IOVANCE BIOTHERAPEUTICS, INC., HALOZYME THERAPEUTICS INC, Adverum Biotechnologies, Inc., Passage BIO, Inc., Trovagene, Inc., AMBIT BIOSCIENCES CORP, and BIOMARIN PHARMACEUTICAL INC.
SEC CIK
Athena Countouriotis's CIK is 0001571469
Past Insider Trading and Trends
2021 was Athena Countouriotis's most active year for acquiring shares with 8 total transactions. Athena Countouriotis's most active month to acquire stocks was the month of January. 2021 was Athena Countouriotis's most active year for disposing of shares, totalling 17 transactions. Athena Countouriotis's most active month to dispose stocks was the month of January. 2019 saw Athena Countouriotis paying a total of $687,975.66 for 102,440 shares, this is the most they've acquired in one year. In 2022 Athena Countouriotis cashed out on 2,152,124 shares for a total of $8,540,731.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -110.96K |
$76.00 | -$8,432,884.00 |
0
|
Aug 17
| |||
Form 4
| +116.75% | 59.43K |
$36.30 | -$107,847.30 | 110.33K |
Feb 9
| |||
Form 4
|
—
|
0
|
$70.34 | -$8,057,037.74 | 50.2K |
Scheduled
|
Feb 9 - Feb 11
| ||
Form 4
| +82.01% | 22.62K |
—
|
—
| 50.2K |
Feb 8
| |||
Form 4
| +18.35% | 4.17K |
$60.00 | $249,960.00 | 26.87K |
May 21
| |||
Form 4
| +3.21% | 706 |
$31.13 | $21,975.66 | 22.71K |
Dec 10 - Jan 6
| |||
Form 4
| +83.33% | 10K |
$45.00 | $450,000.00 | 22K |
Sep 10
| |||
Form 4
|
∞
| 12K |
$18.00 | $216,000.00 | 12K |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Snapshot price: $10.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS INC (HALO) Snapshot price: $59.21
SVP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +42.20% | 11.6K |
$12.26 | -$84,594.00 | 39.08K |
Feb 3
| |||
Form 4
| +37.54% | 7.5K |
—
|
—
| 27.48K |
Jan 5
| |||
Form 4
| +46.51% | 6.34K |
$8.63 | -$923.41 | 19.98K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +45.16% | 4.24K |
$16.39 | -$53,382.23 | 13.64K |
Jan 5
| |||
Form 4
|
∞
| 9.39K |
$17.33 | -$98,001.15 | 9.39K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76
SVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
∞
| 150K |
—
|
—
| 150K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| +112.36% | 10K |
$14.98 | $149,750.00 | 18.9K |
Mar 24
| |||
Form 4
|
∞
| 8.9K |
$18.00 | $160,200.00 | 8.9K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||